Legal & General Group’s Protalix BioTherapeutics PLX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.5K | Buy |
+7,757
| New | +$11.5K | ﹤0.01% | 3232 |
|
|
2024
Q2 | – | Sell |
-5,359
| Closed | -$6.75K | – | 3487 |
|
|
2024
Q1 | $6.75K | Hold |
5,359
| – | – | ﹤0.01% | 3263 |
|
|
2023
Q4 | $9.54K | Hold |
5,359
| – | – | ﹤0.01% | 3244 |
|
|
2023
Q3 | $8.9K | Hold |
5,359
| – | – | ﹤0.01% | 3290 |
|
|
2023
Q2 | $10.7K | Buy |
+5,359
| New | +$10.7K | ﹤0.01% | 3306 |
|